期刊文献+

难治性高血压诊治的研究进展 被引量:4

Research progress in the Diagnosis and Management of Resistant hypertensioi
原文传递
导出
摘要 难治性高血压又称顽固性高血压,是临床上一种特殊类型的高血压,其更易导致心血管疾病及靶器官损伤,因此有效诊断十分重要。本文主要综述了难治性高血压的定义、原因及治疗,以期为临床医师提供难治性高血压诊治的相关思路。 Refractory hypertension,also known as intractable hypertension,is a special type of hypertension in clinic,which is more likely to cause cardiovascular disease and target organ damage,so effective diagnosis is very important.This paper mainly reviewed the definition,causes and treatment of RH,in order to provide clinicians with relevant ideas of RH diagnosis and treatment.
作者 韩魁 张晨 HAN Kui;ZHANG Chen(Community Health Service Center of Jiangqiao Town,Jiading District,Shanghai 201800,China)
出处 《实用心脑肺血管病杂志》 2019年第S02期233-236,共4页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 难治性高血压 病因 治疗 综述 Resistant hypertension Etiology Treatment Review
  • 相关文献

参考文献2

二级参考文献26

  • 1Calhoun DA,Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation, and treatment. A scientific statement fromthe American Heart Association Professional Education Committeeof the Council for High Blood Pressure Research. Hypertension,2008, 51:1403-1419.
  • 2Chobanian AV, Bakris GL, Black HR, et al. Joint NationalCommittee on Prevention,Detection,Evaluation, and Treatmentof High Blood Pressure. National Heart, Lung, and BloodInstitute; National Heart, Lung, and Blood Institute; NationalHigh Blood Pressure Education Program Coordinating Committee.Seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure.Hypertension, 2003,42 : 1206-1252.
  • 3Dahlof B,Sever PS, Poulter NR, et al. ASCOT Investigators.Prevention of cardiovascular events with an antihypertensiveregimen of amlodipine adding perindopril as required versusatenolol adding bendroflumethiazide as required, in the AngloScandinavian Cardiac Outcomes Trial-Blood Pressure LoweringArm ( ASCOT-BPLA) : a multicentre randomised controlled trial.Lancet,2005,366 : 895 -906.
  • 4Jamerson K,Weber MA, Bakris GL, et al. ACCOMPLISH TrialInvestigators. Benazepril plus amlodipine or hydrochlorothiazidefor hypertension in high-risk patients. N Engl J Med,2008,359:2417-2428.
  • 5Schmieder RE,Redon J, Grassi G,et al. ESH position paper:renal denervation - an interventional therapy of resistanthypertension. J Hypertens, 2012, 30:837-841.
  • 6Tsioufis C, Kordalis A, Flessas D, et al. Pathophysiology ofresistant hypertension : the role of sympathetic nervous system.Int J Hypertens, 2011,ID :642416.
  • 7Barajas L,Liu L, Powers K. Anatomy of the renal innervation:intrarenal aspects and ganglia of origin. Can J PhysiolPharmacol, 1992, 70:735-749.
  • 8Hering D,Mahfoud F, Walton AS, et al. Renal denervation inmoderate to severe CKD. J Am Soc Nephrol, 2012, 23 : 1250-1257.
  • 9Laurent S, Schlaich M, Esler M. New drugs, procedures, anddevices for hypertension. Lancet, 2012,380:591-600.
  • 10Aucott L,Poobalan A,Smith WC,et al. Effects of weight loss inoverweight/obese individuals and long-term hyper-tensionoutcomes: a systematic review. Hypertension, 2005,45 : 1035-1041.

共引文献59

同被引文献36

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部